Literature DB >> 15968735

Comparison of six human anti-transglutaminase ELISA-tests in the diagnosis of celiac disease in the Saharawi population.

Eloy Fernández1, Sabino Riestra, Luis Rodrigo, Carlos Blanco, Antonio López-Vázquez, Dolores Fuentes, Maria Moreno, Carlos López-Larrea.   

Abstract

AIM: Celiac disease (CD) is an enteropathic disorder very prevalent in Saharawi people. Our aim was to investigate the diagnostic accuracy of six human tissue transglutaminase (tTG) based ELISA tests in Saharawi CD patients.
METHODS: Fifty-two CD patients and 23 controls were selected from the Saharawi refugee camps in Tinduf. CD patients were divided into two groups according to their anti-endomysium (EmA) status: 41 EmA positive and 11 EmA negative. Sera from patients and controls were tested for human tTG using six commercial ELISA kits. We used receiver operating characteristics (ROC) curves and areas under the curve to compare the diagnostic accuracies of the six assays.
RESULTS: In general, there are differences in the sensitivity and specificity of the human tTG ELISA assays used. Diagnostic accuracy of tests was significantly improved by adjusting the cut-off thresholds according to ROC plot analysis; the correction of the cut-off with the employment of the ROC curve analysis modifies the decision limit in more than 50% in five of the six kits evaluated.
CONCLUSION: Some of the human tTG ELISAs used in this study have a diagnostic accuracy similar to EmA determination for diagnosis of CD in Saharawi people. However, it is necessary to select the assay with a higher sensitivity and specificity, and recalculate the cut-off threshold using samples from the referral population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15968735      PMCID: PMC4316031          DOI: 10.3748/wjg.v11.i24.3762

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease.

Authors:  Katri Kaukinen; Satu Sulkanen; Markku Mäki; Pekka Collin
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-03       Impact factor: 2.566

2.  Identification of tissue transglutaminase as the autoantigen of celiac disease.

Authors:  W Dieterich; T Ehnis; M Bauer; P Donner; U Volta; E O Riecken; D Schuppan
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

Review 3.  HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis.

Authors:  L M Sollid; E Thorsby
Journal:  Gastroenterology       Date:  1993-09       Impact factor: 22.682

4.  Tissue transglutaminase antibodies in patients with end-stage heart failure.

Authors:  Maddalena Peracchi; Cristina Trovato; Massimo Longhi; Maurizio Gasparin; Dario Conte; Cristina Tarantino; Daniele Prati; Maria Teresa Bardella
Journal:  Am J Gastroenterol       Date:  2002-11       Impact factor: 10.864

5.  The distribution of DQ genes in the Saharawi population provides only a partial explanation for the high celiac disease prevalence.

Authors:  C Catassi; M Doloretta Macis; I M Rätsch; S De Virgiliis; F Cucca
Journal:  Tissue Antigens       Date:  2001-12

Review 6.  Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum.

Authors:  A Fasano; C Catassi
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

7.  High rate of positive anti-tissue transglutaminase antibodies in chronic liver disease. Role of liver decompensation and of the antigen source.

Authors:  M Vecchi; C Folli; M F Donato; S Formenti; E Arosio; R de Franchis
Journal:  Scand J Gastroenterol       Date:  2003-01       Impact factor: 2.423

8.  Antibodies against human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease.

Authors:  A Bürgin-Wolff; I Dahlbom; F Hadziselimovic; C J Petersson
Journal:  Scand J Gastroenterol       Date:  2002-06       Impact factor: 2.423

9.  Prevalence of Celiac disease among children in Finland.

Authors:  Markku Mäki; Kirsi Mustalahti; Jorma Kokkonen; Petri Kulmala; Mila Haapalahti; Tuomo Karttunen; Jorma Ilonen; Kaija Laurila; Ingrid Dahlbom; Tony Hansson; Peter Höpfl; Mikael Knip
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

10.  Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study.

Authors:  Antonio Carroccio; Giustina Vitale; Lidia Di Prima; Nadia Chifari; Salvatore Napoli; Cristina La Russa; Gaspare Gulotta; Maurizio R Averna; Giuseppe Montalto; Serafino Mansueto; Alberto Notarbartolo
Journal:  Clin Chem       Date:  2002-09       Impact factor: 8.327

View more
  8 in total

Review 1.  Celiac disease in the East and the West: Bridging the gaps between the guidelines and their implementation in daily practice is mandatory.

Authors:  Anmol Dhawan; Ashish Agarwal; Chris J Mulder; Govind K Makharia
Journal:  Indian J Gastroenterol       Date:  2019-06

2.  Resolution of metabolic syndrome after following a gluten free diet in an adult woman diagnosed with celiac disease.

Authors:  Alvaro García-Manzanares; Alfredo J Lucendo; Sonia González-Castillo; Jesús Moreno-Fernández
Journal:  World J Gastrointest Pathophysiol       Date:  2011-06-15

3.  Serological screening for celiac disease in adults in Japan: Shimane CoHRE study.

Authors:  Mai Fukunaga; Norihisa Ishimura; Takafumi Abe; Miwako Takeda; Minoru Isomura; Yoshikazu Kinoshita; Shunji Ishihara
Journal:  JGH Open       Date:  2020-04-07

4.  Affinity maturation of immunoglobulin A anti-tissue transglutaminase autoantibodies during development of coeliac disease.

Authors:  A Westerlund; M Ankelo; S Simell; J Ilonen; M Knip; O Simell; A E Hinkkanen
Journal:  Clin Exp Immunol       Date:  2007-02-07       Impact factor: 4.330

5.  Celiac disease in non-clinical populations of Japan.

Authors:  Mai Fukunaga; Norihisa Ishimura; Chika Fukuyama; Daisuke Izumi; Nahoko Ishikawa; Asuka Araki; Akihiko Oka; Tomoko Mishiro; Shunji Ishihara; Riruke Maruyama; Kyoichi Adachi; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2017-04-07       Impact factor: 7.527

6.  Prevalence of celiac disease in multiple sclerosis.

Authors:  Luis Rodrigo; Carlos Hernández-Lahoz; Dolores Fuentes; Noemí Alvarez; Antonio López-Vázquez; Segundo González
Journal:  BMC Neurol       Date:  2011-03-07       Impact factor: 2.474

7.  Association between levels of IgA antibodies to tissue transglutaminase and gliadin-related nonapeptides in dermatitis herpetiformis.

Authors:  Justyna Gornowicz-Porowska; Monika Bowszyc-Dmochowska; Agnieszka Seraszek-Jaros; Elżbieta Kaczmarek; Marian Dmochowski
Journal:  ScientificWorldJournal       Date:  2012-04-01

8.  Role of anti-tissue transglutaminase IgA+IgG antibodies in detection of potential celiac disease in patients with type 1 diabetes.

Authors:  Navchetan Kaur; Ranjana W Minz; Sanjay K Bhadada; Biman Saikia; Devi Dayal; Shashi Anand; Neha Joshi; Jagdeep Singh; Babu R Thapa; Rakesh K Kochhar; Kim Vaiphei
Journal:  Indian J Med Res       Date:  2019-01       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.